Tag Archives: Biotech

Serendipity in innovation – Morten Hansen

In this short interview, Morten Hansen talks about his 2011 book co-authored with Jim Collins, Great by Choice.

The book is an account of their research that attempts to explain how companies that outperform their industry peers achieved this superior level (companies such as Amgen, Microsoft, Southwest Airlines, Biomet, Intel, etc.)

Their findings suggest that these companies are not necessarily more innovative, but they navigate uncertain environments with persistence and great ability to prepare for utilizing luck when it comes along. Hence, the key is “serendipity”.

Leave a comment

June 18, 2013 · 1:31 pm

Visual maps of biotech clusters in the U.S.

A great way to take a bird’s eye view of the U.S. life sciences clusters is to look at the BioSpace¬†Hotbed Maps. Although it only displays a very small fraction of the organizations (i.e. major players) in the cluster, it depicts the clusters in an elegant fashion. I hope other industries will follow, not only with decorative maps, but fully informative zoom-able maps. One example is the nanotechnology map from Germany and another is a¬†map of biotech clusters around the world.


Leave a comment

Filed under Organizations & Sociology